Abstract
Knee pain is a widespread musculoskeletal condition affecting millions globally, with significant socio-economic implications. This study endeavors to identify genetic variants associated with knee pain through a comprehensive genome-wide association study (GWAS) using data from 441,757 individuals in the UK Biobank. The primary GWAS identified ten significant loci, including eight novel loci, with the most significant single nucleotide polymorphism (SNP) being rs143384 near the GDF5 gene on chromosome 20 (p = 4.68 × 10-19). In the replication study, seven loci (rs143384, rs919642, rs55760279, rs56076919, rs3892354, rs687878, rs368636424) were found to be significant in the FinnGen cohort. Further, sex-specific analyses revealed distinct genetic associations, identifying three loci (rs143384 with p = 1.70×10-15, rs56076919 with p = 1.60×10-9, rs919642 with p = 1.45×10-8) in females and four loci ( rs2899611 with p = 2.77 × 10-11, rs891720 with p = 5.55 × 10-11, rs2742313 with p = 4.19 × 10-9, rs2019689 with p = 6.51 × 10-9) in males. The phenome-wide association analysis and Mendelian randomization analysis revealed significant links between several phenotypes and knee pain such as leg pain on walking. These findings enhance our understanding of the genetic factors of knee pain, offering potential pathways for therapeutic interventions and personalized medical strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was primarily supported by the Pioneer and Leading Goose R&D Program of Zhejiang Province 2023 (Grant No. 2023C04049) and the Ningbo International Collaboration Program 2023 (Grant No. 2023H025).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study fully complies with the ethical standards and data protection regulations of the UK Biobank. The research was conducted using data from the UK Biobank under Application Number 89386.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
I update the author affiliations.
Data Availability
The summary statistics from the UK Biobank regarding knee pain will be made available upon publication. Additional data relevant to this study, not included in the article or supplementary materials, can be obtained from the authors upon reasonable request.
